Avian Colibacillosis: Pathogenesis, Diagnosis, and Antimicrobial Resistance Patterns in Poultry

Introduction

Avian colibacillosis is a complex infectious disease syndrome of poultry caused by avian pathogenic Escherichia coli (APEC). This condition represents one of the most significant bacterial threats to commercial poultry production worldwide, resulting in substantial economic losses through mortality, reduced feed conversion efficiency, carcass condemnation at slaughter, and increased medication costs [1, 2]. APEC strains are a subset of extraintestinal pathogenic E. coli (ExPEC) that possess a distinct repertoire of virulence factors enabling colonization and invasion of the avian host [3]. The disease manifests in multiple clinical forms including acute septicemia, respiratory tract infection (airsacculitis), pericarditis, perihepatitis, salpingitis, omphalitis (yolk sac infection), and cellulitis [4, 5]. Understanding the molecular mechanisms of pathogenesis, deploying accurate diagnostic strategies, and monitoring antimicrobial resistance patterns are essential components of effective control programs.

Pathogenesis of Avian Colibacillosis

Virulence Factors and Pathogenicity Islands

APEC strains harbor a diverse array of virulence-associated genes that distinguish them from commensal E. coli isolates. These genes are frequently organized on pathogenicity islands (PAIs) or on large conjugative plasmids such as the ColV or ColBM plasmids [6, 7]. The major virulence determinants include adhesins, iron acquisition systems, toxins, protectins, and lipopolysaccharide (LPS) structures.

Adhesins mediate the initial attachment of APEC to host epithelial cells. Type 1 fimbriae (Fim) bind to mannose-containing receptors on respiratory epithelial cells, while P fimbriae (Pap) recognize globoside receptors on renal and reproductive tissues [8, 9]. The temperature-sensitive hemagglutinin (Tsh) and the autotransporter adhesin AatA contribute to adherence to air sac epithelium and collagen matrices respectively [10]. Curli fimbriae facilitate biofilm formation and adhesion to extracellular matrix proteins [11].

Iron acquisition systems are critical for APEC survival within the iron-limited environment of the avian host. The aerobactin siderophore system (iuc/iut genes) and the yersiniabactin system (fyuA/irp genes) chelate ferric iron from host transferrin and lactoferrin [12, 13]. The ColV plasmid-associated genes sitA, iroN, and iucC encode additional iron transporters that enhance bacterial growth in serum and within macrophages [14].

Toxins produced by APEC include hemolysin (HlyA), which forms pores in host cell membranes, and the cytotoxic necrotizing factor 1 (CNF1), which modulates Rho GTPases to disrupt epithelial barrier function [15]. The vacuolating autotransporter toxin (Vat) contributes to airsacculitis and septicemia in experimental infection models [16].

Protectins such as the outer membrane protease OmpT and the capsule polysaccharide (group I and group II capsules) confer resistance to complement-mediated killing and phagocytosis [17]. The increased serum survival protein (Iss) is a major virulence marker associated with APEC pathotypes [18].

Host-Pathogen Interactions and Disease Progression

The pathogenesis of colibacillosis typically follows a multistep process beginning with colonization of the upper respiratory tract. Predisposing factors such as viral infections (e.g., Avian Influenza A(H5N1) in Poultry and Wild Birds: Current Epidemiology, Molecular Diagnostics, and Biosecurity or Infectious Bursal Disease Virus Variants), mycoplasma infections (e.g., Mycoplasma gallisepticum), or environmental stressors (ammonia exposure, temperature fluctuations, high stocking density) compromise the mucociliary clearance mechanism of the trachea [19, 20]. APEC then adheres to and colonizes the damaged respiratory epithelium, subsequently invading the air sacs and causing airsacculitis.

From the air sacs, APEC gains access to the bloodstream through the pulmonary capillary network, resulting in bacteremia and septicemia [21]. The bacteria disseminate to internal organs including the liver, spleen, heart, and pericardium. Fibrinous exudation characterizes the inflammatory response, leading to the hallmark lesions of perihepatitis (fibrinous coating of the liver capsule) and pericarditis (fibrinous pericardial sac thickening) [22]. In laying hens, ascending infection from the cloaca can cause salpingitis and peritonitis, often associated with egg yolk peritonitis [23].

The molecular basis of systemic dissemination involves bacterial evasion of the host complement system. APEC strains expressing the Iss protein and certain O-antigen serotypes resist the bactericidal activity of complement by preventing membrane attack complex (C5b-C9) insertion into the outer membrane [24]. Intracellular survival within heterophils and macrophages allows APEC to evade phagocytic killing and to traffic to secondary sites of infection [25].

Serotypes and Phylogenetic Groups

APEC strains belong predominantly to phylogenetic groups B2 and D, although group A and B1 strains are also isolated from clinical cases [26]. The most frequently reported serogroups associated with avian colibacillosis include O1, O2, O18, O78, and O111 [27]. Serogroup O78 is particularly prevalent in broiler chickens with colisepticemia, while O2 and O1 are commonly isolated from turkeys [28]. The lipopolysaccharide O-antigen structure influences virulence by modulating complement resistance and host inflammatory responses.

Diagnostic Approaches

Clinical and Pathological Examination

Presumptive diagnosis of colibacillosis is based on gross pathological findings at necropsy. Characteristic lesions include fibrinous airsacculitis, pericarditis, perihepatitis, and peritonitis. In acute septicemic cases, splenomegaly, hepatomegaly, and petechial hemorrhages on serosal surfaces may be observed [29]. Omphalitis in neonatal chicks presents as a swollen, discolored yolk sac with caseous exudate. However, gross lesions are not pathognomonic, and laboratory confirmation is required for definitive diagnosis.

Bacteriological Culture and Identification

Isolation of E. coli from affected tissues (liver, spleen, bone marrow, pericardial fluid, or air sac exudate) on selective media such as MacConkey agar or eosin methylene blue (EMB) agar is the standard diagnostic approach [30]. Samples should be collected aseptically from freshly dead or euthanized birds. Lactose-fermenting colonies are presumptively identified as E. coli and confirmed by biochemical testing using commercial identification systems or by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) [31].

Quantitative culture from the bone marrow or spleen provides higher specificity for diagnosing septicemic colibacillosis compared to tracheal or cloacal swabs, which may reflect commensal carriage [32].

Molecular Diagnostic Methods

Polymerase chain reaction (PCR) assays targeting APEC-associated virulence genes offer rapid and specific detection directly from clinical samples or from bacterial isolates. Multiplex PCR panels commonly include genes for iss (increased serum survival), iucD (aerobactin synthesis), tsh (temperature-sensitive hemagglutinin), fimC (type 1 fimbriae), papC (P fimbriae), and irp2 (yersiniabactin synthesis) [33, 34]. A widely used molecular definition of APEC requires the presence of at least two of the following five genes: iss, iucD, tsh, fimC, and irp2 [35].

Real-time quantitative PCR (qPCR) assays enable quantification of bacterial load in tissues and can differentiate APEC from commensal E. coli based on virulence gene profiles [36]. High-resolution melting (HRM) analysis following PCR amplification of the fimH gene allows rapid phylogenetic grouping of isolates [37].

Whole genome sequencing (WGS) has become an increasingly accessible tool for comprehensive characterization of APEC isolates. WGS provides serotype prediction (O and H antigens), multilocus sequence typing (MLST), virulence gene profiling, and antimicrobial resistance gene identification in a single assay [38]. Core genome MLST (cgMLST) offers higher discriminatory power for outbreak investigations and epidemiological tracing compared to conventional MLST [39].

Serological Methods

Enzyme-linked immunosorbent assays (ELISA) for detection of antibodies against APEC O-antigens are used for seroprevalence studies and vaccine response monitoring. The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a methodological parallel for understanding antigen capture principles, although the target antigens differ. Commercial ELISA kits for APEC serology are less widely available than for other poultry pathogens, and most serological testing is performed using in-house assays with formalin-killed whole-cell antigens [40].

Slide agglutination tests using O-specific antisera remain the standard method for serogroup determination of E. coli isolates. A panel of antisera covering the most prevalent APEC serogroups (O1, O2, O18, O78, O111) is typically employed [41].

Diagnostic Decision Workflow

The following Mermaid diagram illustrates a diagnostic decision tree for avian colibacillosis.

flowchart TD
    A[Clinical signs: respiratory distress, depression, mortality], > B[Necropsy examination]
    B, > C{Fibrinous lesions present?}
    C, >|Yes| D[Collect liver, spleen, bone marrow aseptically]
    C, >|No| E[Consider other diagnoses: viral, mycoplasma, nutritional]
    D, > F[Culture on MacConkey/EMB agar 37C 18-24h]
    F, > G{Lactose-fermenting colonies?}
    G, >|Yes| H[Biochemical confirmation or MALDI-TOF MS]
    G, >|No| I[Identify non-lactose fermenters]
    H, > J[APEC virulence gene multiplex PCR]
    J, > K{Two or more virulence genes present?}
    K, >|Yes| L[Confirm APEC; perform serotyping and AST]
    K, >|No| M[Probable commensal E. coli; reassess clinical significance]
    L, > N[Antimicrobial susceptibility testing]
    N, > O[Report resistance profile; guide therapy]
    L, > P[Serotyping with O-antisera]
    P, > Q[Epidemiological typing MLST/WGS]

Antimicrobial Resistance Patterns

Mechanisms of Resistance

APEC strains have acquired resistance to multiple antimicrobial classes through chromosomal mutations and horizontal acquisition of resistance genes on plasmids, transposons, and integrons [42]. The major resistance mechanisms include enzymatic drug inactivation, target site modification, efflux pump overexpression, and reduced membrane permeability.

Beta-lactam resistance in APEC is predominantly mediated by plasmid-borne extended-spectrum beta-lactamases (ESBLs) of the CTX-M, TEM, and SHV families. CTX-M-15 and CTX-M-14 are the most frequently reported ESBL types in poultry isolates globally [43]. AmpC beta-lactamases (CMY-2) confer resistance to third-generation cephalosporins and are often co-located with other resistance genes on conjugative plasmids [44].

Fluoroquinolone resistance arises primarily from point mutations in the quinolone resistance-determining regions (QRDR) of the gyrA and parC genes, encoding DNA gyrase and topoisomerase IV respectively [45]. Plasmid-mediated quinolone resistance (PMQR) genes, including qnr variants, aac(6')-Ib-cr, and oqxAB, contribute to reduced susceptibility and facilitate the selection of high-level resistance mutants [46].

Tetracycline resistance is mediated by ribosomal protection proteins (TetM, TetO) and efflux pumps (TetA, TetB, TetC). The tet(A) gene is the most prevalent tetracycline resistance determinant in APEC isolates [47].

Aminoglycoside resistance results from aminoglycoside-modifying enzymes including acetyltransferases [aac(3)-II, aac(6')-Ib], nucleotidyltransferases [ant(2'')-I], and phosphotransferases [aph(3')-I]. The aac(3)-II gene confers resistance to gentamicin and is frequently linked to class 1 integrons [48].

Colistin Resistance and the mcr Genes

Colistin (polymyxin E) has been used extensively in poultry production for the treatment and prevention of colibacillosis. The emergence of plasmid-mediated colistin resistance encoded by the mcr-1 gene represents a critical development in antimicrobial resistance surveillance [49]. The mcr-1 gene encodes a phosphoethanolamine transferase that modifies lipid A of the LPS, reducing colistin binding affinity. Since its initial description, mcr-2 through mcr-10 variants have been identified, with mcr-1 remaining the most prevalent in poultry isolates [50].

The mcr-1 gene is frequently located on conjugative plasmids of the IncI2, IncX4, and IncHI2 incompatibility groups, facilitating rapid dissemination within and between bacterial populations. Co-carriage of mcr-1 with ESBL genes on the same plasmid has been documented, raising concerns about co-selection under beta-lactam pressure [51].

Prevalence and Epidemiological Trends

Surveillance studies across multiple geographic regions indicate high prevalence of resistance to tetracyclines, sulfonamides, and ampicillin among APEC isolates, with moderate to high resistance to fluoroquinolones and third-generation cephalosporins [52]. Resistance to colistin remains variable, with prevalence rates ranging from less than 1% to over 20% depending on the region and the history of colistin use [53].

Multidrug resistance (MDR), defined as resistance to three or more antimicrobial classes, is common in APEC populations. MDR rates exceeding 50% have been reported in broiler and turkey production systems [54]. The co-localization of resistance genes on mobile genetic elements facilitates the persistence and spread of MDR phenotypes even in the absence of direct selective pressure.

Antimicrobial Susceptibility Testing

Standardized antimicrobial susceptibility testing (AST) for APEC isolates should be performed using broth microdilution or disk diffusion methods following Clinical and Laboratory Standards Institute (CLSI) guidelines. Minimum inhibitory concentration (MIC) determination is preferred for monitoring resistance trends and detecting emerging resistance phenotypes [55].

The following table summarizes commonly tested antimicrobial agents and their resistance mechanisms in APEC.

Implications for Therapy and Control

The high prevalence of MDR among APEC isolates limits therapeutic options for clinical colibacillosis. Fluoroquinolones and third-generation cephalosporins have been mainstays of treatment, but increasing resistance rates necessitate judicious use and reliance on culture-guided therapy [56]. Alternative approaches including the use of bacteriophages, bacteriocins, and immunomodulatory feed additives are under investigation as potential replacements or adjuncts to antimicrobial therapy [57].

Vaccination strategies targeting APEC have been developed using inactivated bacterins, live attenuated strains, and subunit vaccines based on conserved outer membrane proteins or fimbrial antigens. Autogenous vaccines prepared from farm-specific APEC isolates are used in some production systems to address serotype diversity [58]. The Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Antimicrobial Resistance, and Poultry Vaccination article provides additional detail on vaccine development approaches.

Biosecurity measures including all-in/all-out production, effective cleaning and disinfection between flocks, control of viral and mycoplasma coinfections, and optimization of environmental conditions (ventilation, litter management, stocking density) reduce the incidence of colibacillosis and the need for antimicrobial intervention [59].

Conclusion

Avian colibacillosis remains a major challenge for the poultry industry due to the multifactorial nature of the disease, the genetic diversity of APEC strains, and the escalating problem of antimicrobial resistance. Advances in molecular diagnostics, including multiplex PCR and whole genome sequencing, have improved the accuracy of APEC identification and epidemiological characterization. The emergence of plasmid-mediated colistin resistance (mcr genes) and the high prevalence of ESBL-producing isolates underscore the urgency of implementing antimicrobial stewardship programs and developing effective alternative control strategies. Integrated approaches combining improved biosecurity, vaccination, and targeted antimicrobial therapy based on susceptibility testing are essential for sustainable management of colibacillosis in poultry production systems.

References

[1] Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Veterinary Research. 1999;30(2-3):299-316.

[2] Barnes HJ, Nolan LK, Vaillancourt JP. Colibacillosis. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell Publishing; 2008. p. 691-738.

[3] Johnson TJ, Nolan LK. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiology and Molecular Biology Reviews. 2009;73(4):750-774.

[4] Gross WB. Colibacillosis. In: Calnek BW, editor. Diseases of Poultry. 9th ed. Ames: Iowa State University Press; 1991. p. 138-144.

[5] La Ragione RM, Woodward MJ. Virulence factors of Escherichia coli serotypes associated with avian colisepticaemia. Research in Veterinary Science. 2002;73(1):27-35.

[6] Johnson TJ, Wannemuehler YM, Nolan LK. Evolution of the iss gene in Escherichia coli. Applied and Environmental Microbiology. 2008;74(8):2360-2369.

[7] Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Nolan LK. Characterizing the APEC pathotype. Veterinary Microbiology. 2005;110(1-2):125-136.

[8] Dozois CM, Pourbakhsh SA, Fairbrother JM. Expression of P and type 1 fimbriae in pathogenic Escherichia coli from poultry. Veterinary Microbiology. 1995;45(4):297-309.

[9] Marc D, Arne P, Bree A, Dho-Moulin M. Colonization ability and pathogenic properties of a fim- mutant of an avian strain of Escherichia coli. Research in Microbiology. 1998;149(7):473-485.

[10] Stathopoulos C, Provence DL, Curtiss R. Characterization of the avian pathogenic Escherichia coli hemagglutinin Tsh. Infection and Immunity. 1999;67(12):6400-6406.

[11] Olsen A, Wick MJ, Morgelin M, Bjorck L. Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules. Infection and Immunity. 1998;66(3):944-949.

[12] Doetkott C, Nolan LK, Giddings CW, Brown RE. Large plasmids of avian Escherichia coli isolates. Avian Diseases. 1996;40(4):927-930.

[13] Schubert S, Rakin A, Heesemann J. The Yersinia high-pathogenicity island (HPI): evolutionary and functional aspects. International Journal of Medical Microbiology. 2004;294(2-3):83-94.

[14] Johnson TJ, Siek KE, Johnson SJ, Nolan LK. DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli strains. Journal of Bacteriology. 2006;188(2):745-758.

[15] Caprioli A, Falbo V, Roda LG, Ruggeri FM, Zona C. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological changes in cultured cells. Infection and Immunity. 1983;39(3):1300-1306.

[16] Parreira VR, Gyles CL. A novel pathogenicity island integrated adjacent to the thrW tRNA gene of avian pathogenic Escherichia coli. Infection and Immunity. 2003;71(6):3057-3066.

[17] Mellata M, Dho-Moulin M, Dozois CM, Curtiss R, Brown PK, Arne P, et al. Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. Infection and Immunity. 2003;71(1):536-540.

[18] Nolan LK, Horne SM, Giddings CW, Foley SL, Johnson TJ, Lynne AM, et al. Resistance to serum complement, iss, and virulence of avian Escherichia coli. Veterinary Research Communications. 2003;27(2):101-110.

[19] Nagaraja KV, Emery DA, Jordan KA, Newman JA, Pomeroy BS. Scanning electron microscopic studies of adverse effects of ammonia on tracheal mucosa of turkeys. American Journal of Veterinary Research. 1983;44(8):1530-1536.

[20] Van Alstine WG, Arp LH. Effects of Bordetella avium infection on the pulmonary clearance of Escherichia coli in turkeys. American Journal of Veterinary Research. 1987;48(6):922-926.

[21] Pourbakhsh SA, Dho-Moulin M, Bree A, Desautels C, Martineau-Doize B, Fairbrother JM. Localization of the in vivo expression of P and F1 fimbriae in chickens experimentally inoculated with pathogenic Escherichia coli. Microbial Pathogenesis. 1997;22(6):331-341.

[22] Nakamura K, Maeda M, Imada Y, Imada T, Sato K. Pathology of spontaneous colibacillosis in broiler chickens. Avian Pathology. 1985;14(4):523-536.

[23] Bisgaard M, Dam A. Salpingitis in poultry. I. Prevalence, bacteriology, and pathogenesis. Nordisk Veterinaermedicin. 1981;33(3):115-123.

[24] Binns MM, Mayden J, Levine RP. Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT and iss. Infection and Immunity. 1982;35(2):654-659.

[25] Mellata M, Dho-Moulin M, Dozois CM, Curtiss R, Lehoux B, Fairbrother JM. Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages. Infection and Immunity. 2003;71(1):494-503.

[26] Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology. 2000;66(10):4555-4558.

[27] Blanco JE, Blanco M, Mora A, Blanco J. Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain. Journal of Clinical Microbiology. 1997;35(8):2184-2185.

[28] Cloud SS, Rosenberger JK, Fries PA, Wilson RA, Odor EM. In vitro and in vivo characterization of avian Escherichia coli. I. Serotypes, metabolic activity, and antibiotic sensitivity. Avian Diseases. 1985;29(4):1084-1093.

[29] Randall CJ, Reece RL. Color Atlas of Avian Histopathology. London: Mosby-Wolfe; 1996.

[30] Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical Veterinary Microbiology. London: Wolfe Publishing; 1994.

[31] Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clinical Infectious Diseases. 2009;49(4):543-551.

[32] Dho-Moulin M, van den Bosch JF, Girardeau JP, Bree A, Barat T, Lafont JP. Surface antigens from Escherichia coli O2 and O78 strains of avian origin. Infection and Immunity. 1990;58(3):740-745.

[33] Ewers C, Janssen T, Kiessling S, Philipp HC, Wieler LH. Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Veterinary Microbiology. 2004;104(1-2):91-101.

[34] Johnson TJ, Wannemuehler Y, Doetkott C, Johnson SJ, Rosenberger SC, Nolan LK. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. Journal of Clinical Microbiology. 2008;46(12):3987-3996.

[35] Schouler C, Schaeffer B, Bree A, Mora A, Dahbi G, Biet F, et al. Diagnostic strategy for identifying avian pathogenic Escherichia coli based on four patterns of virulence genes. Journal of Clinical Microbiology. 2012;50(5):1673-1678.

[36] Landman WJM, Buter GJ, Dijkman R, van Eck JHH. Quantification of Escherichia coli in the intestines of broiler chickens by real-time PCR. Avian Pathology. 2013;42(4):339-345.

[37] Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, et al. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Applied and Environmental Microbiology.